Skip to content

Dogwood Therapeutics DWTX Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$4.99M+54.4%-$3.78M+51.1%-$15.74M-590%-$3.81M-263%-$10.92M-746%
$17.26K+467%$17.02K+459%
$449.42K+432%$157.86K+68.3%$48.28K-48.8%$65.03K-56.3%$84.47K-39.2%
-$4.59M+2.0%-$3.64M+40.7%-$3.27M-260%-$4.03M-396%-$4.68M-400%
$11.29M+53.2%$32.56K-99.8%$7.37M
$6.7M+149%-$3.6M-128%-$3.27M-234%-$4.15M-747%$2.69M+387%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Dogwood Therapeutics generate?
Dogwood Therapeutics (DWTX) generated -$15.5M in operating cash flow over the trailing twelve months.
Where does Dogwood Therapeutics's cash flow data come from?
Every line is extracted from Dogwood Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.